Loring Wolcott & Coolidge Fiduciary Advisors’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-34
Closed -$2K 838
2017
Q3
$2K Buy
+34
New +$1.74K ﹤0.01% 659

Other funds holding PBH

Loring Wolcott & Coolidge Fiduciary Advisors's PBH Position: Q4 2017 in Review

Loring Wolcott & Coolidge Fiduciary Advisors sold out of Prestige Consumer Healthcare (PBH) in Q4 2017, closing a stake of 34 shares — an estimated $2K sold.

Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in PBH in Q3 2017 and held it in 1 quarter. The position peaked at $2K in Q3 2017. 251 funds tracked by Wall St. Rank hold PBH as of Q4 2017.

  • Loring Wolcott & Coolidge Fiduciary Advisors reported no remaining Prestige Consumer Healthcare position as of Q4 2017 after selling out during the quarter.
  • Loring Wolcott & Coolidge Fiduciary Advisors sold 34 Prestige Consumer Healthcare shares in Q4 2017, an estimated $2K.
  • Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in Prestige Consumer Healthcare in Q3 2017 and held it in 1 quarter.
  • Loring Wolcott & Coolidge Fiduciary Advisors's Prestige Consumer Healthcare position peaked at $2K in Q3 2017.
  • 251 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q4 2017.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q4 2017, filed 8 Feb 2018.